(Q63613451)
Statements
Molecularly-Driven Doublet Therapy for All Children With Refractory or Recurrent CNS Malignant Neoplasms and Young Adults With Refractory or Recurrent SHH Medulloblastoma (English)
0 references
5 March 2018
0 references
February 2025
0 references
108
0 references
39 year
0 references